ScoreComparison
Company
Score
Quality
Valuation
Financial
Technical
Why is Eton Pharmaceuticals, Inc. ?
1
With a growth in Net Sales of 14.03%, the company declared Outstanding results in Mar 26
- The company has declared positive results for the last 2 consecutive quarters
- OPERATING CASH FLOW(Y) Highest at USD 15.84 MM
- RAW MATERIAL COST(Y) Fallen by -6.53% (YoY)
- NET SALES(Q) Highest at USD 24.27 MM
2
High Institutional Holdings at 76.66%
- These investors have better capability and resources to analyse fundamentals of companies than most retail investors.
- Their stake has increased by 4.74% over the previous quarter.
3
Market Beating performance in long term as well as near term
- Along with generating 137.08% returns in the last 1 year, the stock has outperformed S&P 500 in the last 3 years, 1 year and 3 months
Real-Time Research ReportHow much should you buy?
- Overall Portfolio exposure to Eton Pharmaceuticals, Inc. should be less than 10%
- Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is Eton Pharmaceuticals, Inc. for you?
High Risk, High Return
Absolute
Risk Adjusted
Volatility
Eton Pharmaceuticals, Inc.
137.08%
14.54
55.19%
S&P 500
25.41%
1.92
13.25%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
140.77%
EBIT Growth (5y)
14.90%
EBIT to Interest (avg)
-6.66
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
0.52
Sales to Capital Employed (avg)
1.35
Tax Ratio
1.98%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
76.66%
ROCE (avg)
2.75%
ROE (avg)
1.18%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
24.24
EV to EBIT
638.77
EV to EBITDA
155.19
EV to Capital Employed
20.72
EV to Sales
7.99
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
0.23%
ROE (Latest)
-14.09%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Bullish
Bullish
RSI
Bearish
No Signal
Bollinger Bands
Bullish
Bullish
Moving Averages
Bullish (Daily)
KST
Bullish
Mildly Bearish
Dow Theory
Bullish
Bullish
OBV
Mildly Bullish
Mildly Bullish
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend33What is working for the Company
OPERATING CASH FLOW(Y)
Highest at USD 15.84 MM
RAW MATERIAL COST(Y)
Fallen by -6.53% (YoY
NET SALES(Q)
Highest at USD 24.27 MM
OPERATING PROFIT(Q)
Highest at USD 3.54 MM
PRE-TAX PROFIT(Q)
Highest at USD 1.57 MM
NET PROFIT(Q)
Highest at USD 1.55 MM
EPS(Q)
Highest at USD 0.05
-2What is not working for the Company
INTEREST(9M)
At USD 3.56 MM has Grown at 31.36%
Here's what is working for Eton Pharmaceuticals, Inc.
Pre-Tax Profit
At USD 1.57 MM has Grown at 272.87%
over average net sales of the previous four periods of USD -0.91 MMMOJO Watch
Near term Pre-Tax Profit trend is very positive
Pre-Tax Profit (USD MM)
Net Profit
At USD 1.55 MM has Grown at 268.68%
over average net sales of the previous four periods of USD -0.92 MMMOJO Watch
Near term Net Profit trend is very positive
Net Profit (USD MM)
Operating Cash Flow
Highest at USD 15.84 MM
in the last three yearsMOJO Watch
The company has generated higher cash revenues from business operations
Operating Cash Flows (USD MM)
Net Sales
Highest at USD 24.27 MM
in the last five periodsMOJO Watch
Near term sales trend is positive
Net Sales (USD MM)
Net Sales
At USD 24.27 MM has Grown at 21.41%
over average net sales of the previous four periods of USD 19.99 MMMOJO Watch
Near term sales trend is positive
Net Sales (USD MM)
Operating Profit
Highest at USD 3.54 MM
in the last five periodsMOJO Watch
Near term Operating Profit trend is positive
Operating Profit (USD MM)
Pre-Tax Profit
Highest at USD 1.57 MM
in the last five periodsMOJO Watch
Near term Pre-Tax Profit trend is positive
Pre-Tax Profit (USD MM)
Net Profit
Highest at USD 1.55 MM
in the last five periodsMOJO Watch
Near term Net Profit trend is positive
Net Profit (USD MM)
EPS
Highest at USD 0.05
in the last five periodsMOJO Watch
Increasing profitability; company has created higher earnings for shareholders
EPS (USD)
Raw Material Cost
Fallen by -6.53% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin
Raw Material Cost as a percentage of Sales
Depreciation
Highest at USD 1.13 MM
in the last five periodsMOJO Watch
The expenditure on assets done by the company may have gone into operation
Depreciation (USD MM)
Here's what is not working for Eton Pharmaceuticals, Inc.
Interest
At USD 3.56 MM has Grown at 31.36%
over previous Semi-Annual periodMOJO Watch
Rising interest cost signifies increased borrowings
Interest Paid (USD MM)
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
